Prolactin: reference range, hyperprolactinemia, and correct testing
Prolactin is a hormone produced by the anterior pituitary gland, best known for its role in lactation. But its influence extends beyond pregnancy and breastfeeding: it also participates in regulating the menstrual cycle, reproductive function, and immune response. Unlike most laboratory markers, prolactin is unusually sensitive to situational factors — stress, sleep, food, sexual activity, and even the venepuncture itself.
This is why correct preparation for the test is critically important for an interpretable result. An elevated prolactin on a report is not always pathological: in most cases, a single isolated elevation warrants a repeat test under proper conditions — not immediate treatment.
What prolactin does
Prolactin is synthesised by lactotroph cells of the anterior pituitary. During pregnancy its level rises gradually and peaks at delivery, preparing the mammary glands for lactation. After birth, prolactin falls rapidly in women who are not breastfeeding; in those who are, it remains elevated for the duration of lactation.
Outside of pregnancy, prolactin is regulated by tonic inhibition: dopamine produced in the hypothalamus continuously suppresses its secretion. This mechanism explains why drugs that block dopamine receptors (antipsychotics, metoclopramide) raise prolactin, while dopaminergic agonists (bromocriptine, cabergoline) lower it.
Prolactin also acts on the hypothalamic-pituitary-ovarian axis: in hyperprolactinaemia, pulsatile release of GnRH (gonadotrophin-releasing hormone) is disrupted, suppressing FSH and LH levels. The clinical consequence is impaired ovulation, menstrual dysfunction, or infertility.
Prolactin performs other, less well-known functions — it participates in fluid-electrolyte balance, immune response, and osmoregulation. However, the clinically relevant effects are predominantly those related to lactation and reproductive function, as these are the ones that produce the symptoms prompting a test.
Prolactin reference ranges
| Category | Range (ng/mL) |
|---|---|
| Men | 4–15 |
| Non-pregnant women | 4–25 |
| Pregnancy (rises across trimesters) | 10–300 |
Reference limits vary between laboratories depending on the method and reagents used. Some laboratories report in mIU/L: 1 ng/mL ≈ 21 mIU/L. Always compare your result to the reference range printed on your own laboratory’s report, not to generic tables from the internet.
During pregnancy, prolactin rises gradually from the first to third trimester: in the first trimester values are typically 10–50 ng/mL; by the third trimester they may reach 200–300 ng/mL or higher. Values exceeding the table above during pregnancy do not in themselves indicate pathology and require assessment by an obstetrician or endocrinologist in clinical context.
Causes of elevated prolactin
Physiological — the most common cause of mild elevation on a lab report:
- Stress (including the stress of the blood draw itself)
- Recent sleep (prolactin is naturally elevated overnight and immediately after waking)
- Sexual activity the evening before
- Intense physical exercise
- Breastfeeding or nipple stimulation (including a clinical breast examination)
- Eating immediately before the blood draw
Pharmacological — the second most common cause, especially important for differential diagnosis:
- Antipsychotics — particularly risperidone and amisulpride
- Metoclopramide and domperidone
- Certain antidepressants (SSRIs — moderate effect)
- Oestrogens (including combined oral contraceptives)
- Verapamil
- Opioids
Pathological — organic causes that require investigation:
- Prolactinoma — a benign pituitary adenoma. Microprolactinoma: size < 10 mm; macroprolactinoma: ≥ 10 mm. A prolactin level > 200 ng/mL substantially increases the probability of prolactinoma.
- Hypothyroidism — thyrotrophin-releasing hormone (TRH) stimulates prolactin; this cause should be excluded when prolactin is elevated.
- Empty sella syndrome
- Compression of the pituitary stalk by another tumour (stalk effect)
- Chronic kidney disease — reduced prolactin clearance
Macroprolactin and repeat testing
Not all “prolactin” measured in a standard laboratory assay is biologically active. Macroprolactin is a complex of prolactin molecules bound to IgG antibodies; it is biologically inactive but reacts in standard immunoassays in the same way as the active form. Macroprolactinaemia is found in approximately 10–20% of people with elevated total prolactin and can produce a false-positive result.
If your prolactin is elevated but you have no symptoms of hyperprolactinaemia (normal cycle, no galactorrhoea, no infertility), the laboratory can perform polyethylene glycol (PEG) precipitation to rule out macroprolactin — on clinician referral.
A single elevated prolactin value WITHOUT a matching clinical picture is a reason to repeat the test under proper conditions, not grounds for a diagnosis.
One further point: different immunoassay methods detect prolactin differently. The hook effect — a spuriously low result caused by very high prolactin concentrations in macroprolactinoma — is a technical artefact of some analysers. If the clinical picture is typical of macroprolactinoma but the result is unexpectedly low, the laboratory can repeat the assay on a diluted sample — on clinician referral.
Link to menstrual irregularities
Hyperprolactinaemia suppresses pulsatile GnRH release, reducing FSH and LH levels and disrupting ovulation. Clinical manifestations include amenorrhoea, oligomenorrhoea, anovulatory cycles, infertility, and galactorrhoea (milk discharge outside of pregnancy and lactation).
When investigating cycle irregularities, prolactin is always assessed alongside FSH and LH: elevated prolactin can explain secondarily suppressed gonadotrophins. An important pattern: the higher the prolactin level, the more likely an organic cause. Pituitary MRI is not the first step for any elevated result, however: the clinician first repeats the test with proper preparation and rules out medication effects, hypothyroidism, chronic kidney disease, and macroprolactin. Pituitary imaging is considered for persistently elevated prolactin — especially well above 100 ng/mL, or with symptoms such as visual disturbances or headache — and the decision belongs to an endocrinologist.
Important: galactorrhoea is not present in all women with hyperprolactinaemia — the absence of breast discharge does not exclude pathologically elevated prolactin. Conversely, in women who have recently stopped breastfeeding, residual galactorrhoea can persist for some time despite a normal prolactin level.
How to test correctly
Preparation for a prolactin test is the single most important step for obtaining an interpretable result. Prolactin is the one hormone where preparation matters more than the assay itself: with ideal preparation the result is reproducible; with poor preparation, even a normal level can appear elevated.
- Timing: morning, 7:00–10:00. Prolactin is highest overnight and immediately after waking, then falls gradually. The optimal window is 1–2 hours after waking, once the nocturnal peak has passed.
- Rest: sit quietly for at least 30 minutes before the blood draw. Rushing, anxiety, and the venepuncture itself all raise prolactin.
- Food and caffeine: do not eat or drink coffee immediately before the test (food causes a moderate rise; water is fine).
- Sexual activity and exercise: avoid both on the day before.
- Nipple stimulation: avoid on the day of the draw — including a clinical breast examination.
- Medications: if you are taking any medication from the list above, inform your clinician. In some cases it may be appropriate to temporarily withhold the medication before testing, but only in agreement with the prescribing clinician.
- Repeat testing: if the first result is elevated but the preparation was not ideal, repeat under all the correct conditions before proceeding to imaging.
Adhering to these conditions substantially reduces false-positive results and helps avoid unnecessary investigation. The clinician ordering the test should be aware of all these details — they are part of the clinical interpretation.
How HealthLab helps track trends
Prolactin is a marker that needs tracking over time — both at initial elevation (to confirm or exclude after proper preparation) and during treatment (to see the response to therapy). A single value on a report is a snapshot; a trend across several measurements is the real picture.
HealthLab automatically recognises prolactin and other hormones from PDF lab reports issued by any laboratory, and builds a trend chart over time. You can see immediately whether the value is changing — without manual data entry or scattered paperwork. All values are stored in one place alongside reference range boundaries and are accessible at any time.
Download HealthLab on the App Store
Frequently asked questions
My prolactin is mildly elevated — does that mean I have a prolactinoma?
Not necessarily. Prolactin > 200 ng/mL is a strong indicator of prolactinoma and requires pituitary MRI. Values < 100 ng/mL are in most cases explained by physiological or pharmacological causes. Values between 100 and 200 ng/mL represent an intermediate zone requiring clinical assessment. The first step is always to repeat the test under proper conditions — morning, 1–2 hours after waking, 30 minutes of quiet rest beforehand, no food before the draw. Only if the elevation is confirmed on repeat measurement will the clinician proceed to further investigation.
Do I need to order a separate macroprolactin test?
There is no separate test called “macroprolactin” — it is an additional processing step performed in the same laboratory. The PEG precipitation test is carried out only when total prolactin is elevated WITHOUT an obvious clinical explanation, and only on clinician referral. It should not be ordered independently as a routine screen.
Which medications most commonly raise prolactin?
The most marked effect comes from antipsychotics — particularly risperidone and amisulpride, which can raise prolactin 5–10 times above normal. Metoclopramide and domperidone (antiemetics) also cause substantial rises. Certain SSRIs produce a moderate elevation. Oestrogens, verapamil, and opioids have a less pronounced but real effect. If you are taking any of these medications, discuss with your clinician how to account for this when interpreting your result.
Can I take the prolactin test on any day of my cycle?
Yes. The phase of the menstrual cycle has minimal influence on prolactin — unlike FSH, LH, or estradiol. Far more important are the time of day (morning, 1–2 hours after waking), a calm state before the draw, and the absence of situational factors that raise prolactin.
Related
References
- Melmed et al. — Diagnosis and Treatment of Hyperprolactinemia: An Endocrine Society Clinical Practice Guideline (J Clin Endocrinol Metab, 2011)
- AACE/ACE Disease State Clinical Review: Diagnosis and Treatment of Prolactinomas (Endocr Pract, 2011)
- Pituitary Society — Consensus on diagnosis and treatment of prolactinomas (Pituitary, 2006)
- NICE CKS — Hyperprolactinaemia